{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-017646","form_type":"8-K","ticker":"NSPR","cik":"0001433607","company_name":"InspireMD, Inc.","filed_at":"2023-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.849233+00:00","generated_at":"2026-06-14T23:31:12.358211+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"InspireMD Q1 revenue up 4.7% to $1.24M; net loss $4.3M; completed $42.2M private placement","bullets":["Q1 2023 revenue $1.239M (+4.7% YoY); CGuard EPS revenue $1.239M (+6.7% YoY); net loss $4.256M ($0.53/sh).","Cash & equivalents $12.9M as of March 31, 2023; subsequent to quarter, completed $42.2M upfront private placement for up to $113.6M.","CE Mark reinstated under MDD in mid-March; shipments resumed; working through backlog; awaiting MDR recertification.","US IDE trial enrollment on track to complete by end of Q2 2023; FDA approved CGuard Prime delivery system for trial.","Hired Shane Gleason as GM of North America and VP Global Marketing; promoted Andrea Tommasoli to COO."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-017646","json":"https://secwatch.observer/filing/0001493152-23-017646.json","markdown":"https://secwatch.observer/filing/0001493152-23-017646.md","text":"https://secwatch.observer/filing/0001493152-23-017646.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1433607/000149315223017646/0001493152-23-017646-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1433607/000149315223017646/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T23:31:12.358211+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"715e4df9b30ed22821b0dd17c1bae1d9d45767eb","claim":"InspireMD, Inc. reported first quarter ended March 31, 2023 results: revenue $1,239,000.","evidence_excerpt":"For the three months ended March 31, 2023, revenue increased by $56,000, or 4.7%, to $1,239,000, from $1,183,000 during the three months ended March 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315223017646/0001493152-23-017646-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$1,239,000"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}